Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRIG1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
mRNA | SERPINH1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | HIST1H1T | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | AL022578.1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
mRNA | BAALC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | OR4C11 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
mRNA | COX17 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
mRNA | ADAMTS14 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
mRNA | NFIC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
mRNA | SECISBP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |